Send to

Choose Destination
Muscle Nerve. 2004 Jul;30(1):114-7.

Mutation analysis of two patients with hypokalemic periodic paralysis and suspected malignant hyperthermia.

Author information

Malignant Hyperthermia Investigation Unit, Academic Unit of Anesthesia, Level 8 Clinical Sciences Building, St. James University Hospital, Beckett Street, Leeds LS9 7TF, UK.


Hypokalemic periodic paralysis (HypoPP) and malignant hyperthermia (MH) are autosomal-dominant genetically heterogeneous ion channelopathies. MH has been described in patients with HypoPP, suggesting a potential link between these disorders. However, a common genetic determinant has not been described. With the aim of corroborating this association, four candidate genes were screened in two independent HypoPP patients, one of whom was also diagnosed as MH-susceptible and the other as MH-normal by the in vitro contracture test (IVCT). An A>G change at nucleotide 7025 was detected in the RYR1 gene in the HypoPP/MH-susceptible patient. Detection of the same mutation in three independent MH families suggested that 7025A>G represents a novel MH-susceptibility allele and that MH and HypoPP occurred independently in the case presented. Conclusive evidence in support of the hypothesis that MH and HypoPP are allelic was therefore not obtained.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center